JP2022527395A5 - - Google Patents

Info

Publication number
JP2022527395A5
JP2022527395A5 JP2021559883A JP2021559883A JP2022527395A5 JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5 JP 2021559883 A JP2021559883 A JP 2021559883A JP 2021559883 A JP2021559883 A JP 2021559883A JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
pharmaceutically acceptable
conditions
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559883A
Other languages
English (en)
Japanese (ja)
Other versions
JP7577682B2 (ja
JP2022527395A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027203 external-priority patent/WO2020210308A1/en
Publication of JP2022527395A publication Critical patent/JP2022527395A/ja
Publication of JP2022527395A5 publication Critical patent/JP2022527395A5/ja
Application granted granted Critical
Publication of JP7577682B2 publication Critical patent/JP7577682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559883A 2019-04-10 2020-04-08 ガレクチン-3の低分子阻害剤 Active JP7577682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962831753P 2019-04-10 2019-04-10
US62/831,753 2019-04-10
PCT/US2020/027203 WO2020210308A1 (en) 2019-04-10 2020-04-08 Small molecule inhibitors of galectin-3

Publications (3)

Publication Number Publication Date
JP2022527395A JP2022527395A (ja) 2022-06-01
JP2022527395A5 true JP2022527395A5 (cg-RX-API-DMAC10.html) 2023-04-17
JP7577682B2 JP7577682B2 (ja) 2024-11-05

Family

ID=70476468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559883A Active JP7577682B2 (ja) 2019-04-10 2020-04-08 ガレクチン-3の低分子阻害剤

Country Status (6)

Country Link
US (1) US12269819B2 (cg-RX-API-DMAC10.html)
EP (1) EP3953349A1 (cg-RX-API-DMAC10.html)
JP (1) JP7577682B2 (cg-RX-API-DMAC10.html)
KR (1) KR102890853B1 (cg-RX-API-DMAC10.html)
CN (1) CN113710665A (cg-RX-API-DMAC10.html)
WO (1) WO2020210308A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102863667B1 (ko) 2019-08-09 2025-09-23 이도르시아 파마슈티컬스 리미티드 (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체
US12404295B2 (en) 2019-08-09 2025-09-02 Idorsia Pharmaceuticals Ltd (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives
MA56883B1 (fr) 2019-08-15 2025-04-30 Idorsia Pharmaceuticals Ltd Dérivés de 2-hydroxycycloalcane-1-carbamoyle
CN114585619B (zh) 2019-08-29 2024-09-27 爱杜西亚药品有限公司 α-D-吡喃半乳糖苷衍生物
WO2021231243A1 (en) * 2020-05-11 2021-11-18 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
WO2022073969A1 (en) 2020-10-06 2022-04-14 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
US12291520B2 (en) 2020-11-02 2025-05-06 Idorsia Pharmaceuticals Ltd Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
JP7844491B2 (ja) 2021-02-09 2026-04-13 イドルシア・ファーマシューティカルズ・リミテッド ヒドロキシヘテロシクロアルカン-カルバモイル誘導体
WO2022184755A1 (en) * 2021-03-03 2022-09-09 Idorsia Pharmaceuticals Ltd Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
US9021050B2 (en) 2012-08-31 2015-04-28 Yume, Inc. Network service system and method with off-heap caching
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
IN2015DN02573A (cg-RX-API-DMAC10.html) 2012-10-31 2015-09-11 Galecto Biotech Ab
CA2970062C (en) 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
JP6844991B2 (ja) 2015-11-10 2021-03-17 サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスSanko Tekstil Isletmeleri San. Ve Tic. A.S. ジッパーを有する伸縮性衣類の製法
KR102626669B1 (ko) 2017-05-12 2024-01-17 갈랙틴 사이언시즈, 엘엘씨 질환의 예방 및 치료를 위한 화합물 및 이의 용도
CA3062649A1 (en) * 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the treatment of systemic insulin resistance disorders and the use thereof
US11267811B2 (en) * 2017-09-27 2022-03-08 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3

Similar Documents

Publication Publication Date Title
JP2022527075A5 (cg-RX-API-DMAC10.html)
JP2025512474A5 (cg-RX-API-DMAC10.html)
JP2021527102A5 (cg-RX-API-DMAC10.html)
JP2016517432A5 (cg-RX-API-DMAC10.html)
BRPI0712268A2 (pt) composição para diagnóstico de doença relacionada à amilóide
JP7577682B2 (ja) ガレクチン-3の低分子阻害剤
JP2019504898A5 (cg-RX-API-DMAC10.html)
JP2021523887A (ja) XIIa因子インヒビター
JP2023531709A5 (cg-RX-API-DMAC10.html)
RU2008112184A (ru) Производное тиазола
EP3793995B1 (en) Matrix metalloproteinase (mmp) inhibitors and methods of use thereof
RU2018131440A (ru) Антагонисты FimH, являющиеся производными маннозы, пригодные для лечения заболевания
CN102149682B (zh) 1-(取代芳基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐的制备方法及其用途
JP2021528451A5 (cg-RX-API-DMAC10.html)
JP2022545158A5 (cg-RX-API-DMAC10.html)
JP2023531495A5 (cg-RX-API-DMAC10.html)
JP2006522824A5 (cg-RX-API-DMAC10.html)
JP2023527396A5 (cg-RX-API-DMAC10.html)
WO2007002637B1 (en) N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JP6667507B2 (ja) ピラゾロ[3,4−c]ピリジン誘導体
JP2023524996A5 (cg-RX-API-DMAC10.html)
JP2010505869A5 (cg-RX-API-DMAC10.html)
JP2023525527A5 (cg-RX-API-DMAC10.html)
PT93994B (pt) Processo para a preparacao de novas arilsulfonamidas e de composicoes farmaceuticas que as contem
JP2006506350A5 (cg-RX-API-DMAC10.html)